Terns Pharmaceuticals Inc (TERN)
6.55
-0.23
(-3.39%)
USD |
NASDAQ |
Nov 14, 16:00
6.56
+0.01
(+0.15%)
After-Hours: 20:00
Terns Pharmaceuticals Free Cash Flow (Quarterly): -16.19M for June 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | -16.19M |
March 31, 2024 | -22.83M |
December 31, 2023 | -19.36M |
September 30, 2023 | -20.71M |
June 30, 2023 | -12.99M |
March 31, 2023 | -14.38M |
December 31, 2022 | -11.24M |
September 30, 2022 | -13.43M |
June 30, 2022 | -11.17M |
Date | Value |
---|---|
March 31, 2022 | -13.54M |
December 31, 2021 | -10.87M |
September 30, 2021 | -8.156M |
June 30, 2021 | -8.802M |
March 31, 2021 | -14.34M |
December 31, 2020 | -7.434M |
September 30, 2020 | -6.318M |
June 30, 2020 | -8.924M |
March 31, 2020 | -7.717M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-22.83M
Minimum
Mar 2024
-6.318M
Maximum
Sep 2020
-12.69M
Average
-12.12M
Median
Free Cash Flow (Quarterly) Benchmarks
Eli Lilly and Co | -458.90M |
Viking Therapeutics Inc | -21.96M |
Biomarin Pharmaceutical Inc | 200.30M |
Elite Pharmaceuticals Inc | 1.466M |
Verrica Pharmaceuticals Inc | -8.574M |